Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial

Eur Heart J. 2024 Apr 21;45(16):1481-1483. doi: 10.1093/eurheartj/ehad890.
No abstract available

Keywords: Angiotensin receptor neprilysin inhibitor; Congenital heart disease; Heart failure; Systemic right ventricle; Transposition of the great arteries.

Publication types

  • Clinical Trial

MeSH terms

  • Heart Failure* / drug therapy
  • Heart Ventricles
  • Humans
  • Neprilysin
  • Receptors, Angiotensin / therapeutic use
  • Transposition of Great Vessels*
  • Vascular Diseases*
  • Ventricular Dysfunction, Right*
  • Ventricular Function, Right

Substances

  • Neprilysin
  • Receptors, Angiotensin